Oclorus™Spermidine Supplement
  • Home
  • Fisetin
  • Dasatinib-Quercetin
  • Navitoclax (ABT-263)
  • UBX1325
  • More
    • Home
    • Fisetin
    • Dasatinib-Quercetin
    • Navitoclax (ABT-263)
    • UBX1325
Oclorus™Spermidine Supplement
  • Home
  • Fisetin
  • Dasatinib-Quercetin
  • Navitoclax (ABT-263)
  • UBX1325

Health & Safety / Research Use Only Statement – Mitora™

All products provided by Mitora™, including senolytic compounds such as Fisetin, Quercetin, Dasatinib, UBX1325, Piperlongumine, Navitoclax (ABT-263), 17-DMAG, and Ouabain, are intended for research and laboratory use only.

Key Points:

  • Not for human or veterinary use.
     
  • Not intended for clinical, therapeutic, or diagnostic applications.
     
  • Users must follow appropriate laboratory safety procedures, including handling, storage, and disposal in accordance with institutional, local, and national regulations.
     
  • Safety Data Sheets (SDS) are provided for all products.
     

By using Mitora™ products, you agree to comply with all health and safety regulations applicable in your jurisdiction and research facility.

2. Export Control / Compliance Statement – Mitora™

Mitora™ is committed to full compliance with international export control laws and regulations, including but not limited to U.S. Export Administration Regulations (EAR) and other applicable national or regional laws.

Key Points:

  • All senolytic compounds supplied by Mitora™ are for research purposes only and are subject to export control restrictions.
     
  • Buyers are responsible for ensuring compliance with import/export laws in their country, including obtaining necessary licenses or permits.
     
  • Mitora™ may refuse orders that violate any export control or restricted-use regulations.
     

By purchasing from Mitora™, customers certify that the products will not be resold, transferred, or used in violation of applicable laws.


Copyright©2023 Mitora™

Powered by Mitora™

  • Cardiac glycosides
  • Navitoclax-ABT-263
  • Ouabain–Cardiac Glycoside
  • Piperlongumine
  • 17-DMAG–HSP90 Inhibitor
  • Quality & Technology
  • About Us
  • Terms of Service
  • Privacy Policy
  • FAQ
  • Contact Us
  • Senolytic Compound News
  • Equal Opportunity
  • Legal Disclaimer–Mitora™
  • Health & Safety–Mitora™
  • Accessibility Statement

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept